Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
There is no responsible universal answer
These structural insights could prove valuable for the development of new treatments for neurocysticercosis, benefiting affected populations worldwide
By effectively targeting mitochondrial metabolism and FLT3 mutation, TMQ0153 is a promising strategy for relapsed AML
10.1038/ncb3064 Nat
Effects in active malignancy are not well characterized, and most clinicians treat this as an exclusion until more data exists
Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump
US$ 22.33
US$ 29.47
US$ 22.57
US$ 24.55
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)
US$ 27.84
US$ 22.08
US$ 20.72
US$ 24.07
,type=downsize)
